A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors
Cantargia AB
Cantargia AB
Eastern Cooperative Oncology Group
Nektar Therapeutics
Augusta University
Masonic Cancer Center, University of Minnesota
Hoosier Cancer Research Network
University of Arizona
Asan Medical Center
University of Southern California
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company